BRIEF published on 11/06/2024 at 15:06, 17 days 21 hours ago The Vanguard Group Discloses Stake in AngloGold Ashanti plc Ordinary Shares Takeover Code Vanguard Group Stake Disclosure AngloGold Ashanti
BRIEF published on 11/06/2024 at 15:05, 17 days 21 hours ago The Vanguard Group Discloses Significant Stake in SEGRO plc Securities Form 8.3 Stake Vanguard SEGRO
PRESS RELEASE published on 11/06/2024 at 15:04, 17 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: StoneX Group Inc. The Vanguard Group, Inc. discloses a 5.96% position in StoneX Group Inc. as of 05/11/2024 through Form 8.3, in compliance with the Takeover Code Form 8.3 Position Disclosure Takeover Code Vanguard Group StoneX Group
BRIEF published on 11/06/2024 at 15:04, 17 days 21 hours ago The Vanguard Group Discloses Position in Hargreaves Lansdown Financial Position Takeover Code Securities Disclosure Vanguard Group Hargreaves Lansdown
BRIEF published on 11/06/2024 at 15:03, 17 days 21 hours ago Vanguard's Position in Smith (DS) plc Takeover Code Securities Disclosure Vanguard Group Smith (DS) Plc International Paper
PRESS RELEASE published on 11/06/2024 at 15:02, 17 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company The Vanguard Group, Inc. discloses a 11.79% stake in International Paper Company as of 05 November 2024. Additional disclosures made in relation to Smith (DS) plc Vanguard Group Stake Disclosure Stock Holdings International Paper Company Smith Plc
PRESS RELEASE published on 11/06/2024 at 15:01, 17 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc The Vanguard Group, Inc. discloses a 4.06% stake in AngloGold Ashanti plc. Form 8.3 filed on 06-Nov-2024 Form 8.3 Vanguard Group Financial Disclosure Stake Disclosure AngloGold Ashanti Plc
PRESS RELEASE published on 11/06/2024 at 15:00, 17 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.16% interest in SEGRO plc in accordance with Rule 8.3 of the Takeover Code on 05 Nov 2024 The Vanguard Group, Inc. Rule 8.3 Takeover Code Interest Disclosure SEGRO PLC
PRESS RELEASE published on 11/06/2024 at 14:59, 17 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc The Vanguard Group, Inc. discloses a 3.95% stake in Hargreaves Lansdown plc as of 05 Nov 2024, with 10,758 shares purchased at 10.90 GBP per unit Vanguard Group Financial Disclosure Share Purchase Stake Disclosure Hargreaves Lansdown Plc
PRESS RELEASE published on 11/06/2024 at 14:58, 17 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses a 4.90% interest in Smith (DS) plc through relevant securities. International Paper Company also involved Relevant Securities Disclosure The Vanguard Group Smith (DS) Plc Interests
Published on 11/22/2024 at 23:55, 1 day 12 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 13 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 13 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 14 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 18 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 18 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 19 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 3 days 5 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 17 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 18 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 18 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
